RESUMO
BACKGROUND: L-arginase, is a powerful anticancer that hydrolyzes L-arginine to L-ornithine and urea. This enzyme is widely distributed and expressed in organisms like plants, fungi, however very scarce from bacteria. Our study is based on isolating, purifying, and screening the marine bacteria that can produce arginase. RESULTS: The highest arginase producing bacteria will be identified by using microbiological and molecular biology methods as Bacillus licheniformis OF2. Characterization of arginase is the objective of this study. The activity of enzyme was screened, and estimated beside partial sequencing of arginase gene was analyzed. In silico homology modeling was applied to generate the protein's 3D structure, and COACH and COFACTOR were applied to determine the protein's binding sites and biological annotations based on the I-TASSER structure prediction. The purified enzyme was undergone an in vitro anticancer test. CONCLUSIONS: L-arginase demonstrated more strong anti-cancer cells with an IC50 of 21.4 ug/ml in a dose-dependent manner. L-arginase underwent another investigation for its impact on the caspase 7 and BCL2 family of proteins (BCL2, Bax, and Bax/Bcl2). Through cell arrest in the G1/S phase, L-arginase signals the apoptotic cascade, which is supported by a flow cytometry analysis of cell cycle phases.
Assuntos
Arginase , Bacillus licheniformis , Arginase/genética , Arginase/metabolismo , Bacillus licheniformis/genética , Bacillus licheniformis/metabolismo , Proteína X Associada a bcl-2/genética , Arginina/metabolismo , Ornitina/metabolismo , Proteínas Proto-Oncogênicas c-bcl-2RESUMO
The present investigation entails the fabrication and characterization of nanometric emulsion of eugenol (Nm-eugenol) encompassed into chitosan for assessing bio-efficacy in terms of in vitro antifungal actions, antiaflatoxigenic potential, and in situ preservative efficacy against Aspergillus flavus infestation and aflatoxin B1 (AFB1) mediated loss of dietary minerals, lipid triglycerides and alterations in composition of important macronutrients in stored rice. Nm-eugenol characterized by SEM, XRD, and FTIR exhibited biphasic burst release of eugenol. Reduction in ergosterol and methylglyoxal (AFB1-inducer) content after Nm-eugenol fumigation depicted biochemical mechanism of antifungal and antiaflatoxigenic activities. In silico 3D homology docking of eugenol with Ver-1 gene validated molecular mechanism of AFB1 inhibition. Further, significant protection of rice seeds from fungi, AFB1 contamination and preservation against loss of rice minerals, macronutrients and lipids during storage suggested deployment of chitosan as a biocompatible wall material for eugenol encapsulation and application as novel green preservative for food protection.
Assuntos
Aflatoxina B1/antagonistas & inibidores , Anti-Infecciosos/farmacologia , Aspergillus flavus/efeitos dos fármacos , Quitosana/química , Eugenol/farmacologia , Proteínas Fúngicas/antagonistas & inibidores , Nanoestruturas/química , Aflatoxina B1/química , Aflatoxina B1/metabolismo , Aflatoxina B1/toxicidade , Anti-Infecciosos/metabolismo , Aspergillus flavus/crescimento & desenvolvimento , Aspergillus flavus/metabolismo , Sítios de Ligação , Composição de Medicamentos/métodos , Liberação Controlada de Fármacos , Grão Comestível , Emulsões , Ergosterol/antagonistas & inibidores , Ergosterol/metabolismo , Eugenol/metabolismo , Conservação de Alimentos/métodos , Proteínas Fúngicas/química , Proteínas Fúngicas/metabolismo , Humanos , Cinética , Simulação de Acoplamento Molecular , Nanoestruturas/ultraestrutura , Nutrientes/análise , Oryza/efeitos dos fármacos , Oryza/microbiologia , Ligação Proteica , Conformação Proteica em alfa-Hélice , Conformação Proteica em Folha beta , Aldeído Pirúvico/antagonistas & inibidores , Aldeído Pirúvico/metabolismo , Triglicerídeos/análiseRESUMO
Sensing potentially harmful bitter substances in the oral cavity is achieved by a group of (Ë) 25 receptors, named TAS2Rs, which are expressed in specialized sensory cells and recognize individual but overlapping sets of bitter compounds. The receptors differ in their tuning breadths ranging from narrowly to broadly tuned receptors. One of the most broadly tuned human bitter taste receptors is the TAS2R14 recognizing an enormous variety of chemically diverse synthetic and natural bitter compounds, including numerous medicinal drugs. This suggests that this receptor possesses a large readily accessible ligand binding pocket. To allow probing the accessibility and size of the ligand binding pocket, we chemically modified cognate agonists and tested receptor responses in functional assays. The addition of large functional groups to agonists was usually possible without abolishing agonistic activity. The newly synthesized agonist derivatives were modeled in the binding site of the receptor, providing comparison to the mother substances and rationalization of the in vitro activities of this series of compounds.